Catalyst Pharmaceutical
CPRX
CPRX
98 hedge funds and large institutions have $131M invested in Catalyst Pharmaceutical in 2018 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 19 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
40% less capital invested
Capital invested by funds: $219M → $131M (-$88.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
98
Holding in Top 10
–
Calls
$60K
Puts
$78K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.62M | |
| 3 | +$1.4M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$1.25M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.14M |
Top Sellers
| 1 | -$4.81M | |
| 2 | -$3.52M | |
| 3 | -$3.09M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.68M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.25M |